BioCardia, Inc. Reports Results for Quarter Ended June 30, 2026

What Happened BioCardia, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release issued on August 12, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K filing under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 12, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter ended June 30, 2026.
• Exhibit: press release furnished as Exhibit 99.1 to the 8-K.
• Interactive data: Cover Page Interactive Data File embedded within the Inline XBRL document (listed in Item 9.01).

Why It Matters This 8-K signals the company has publicly released its latest quarterly results — a primary source for investors seeking current revenue, profit/loss, and operational updates. The 8-K itself furnishes the press release but does not reproduce detailed financial tables within the filing text; investors should read Exhibit 99.1 and the company’s subsequent 10-Q (if filed) for full figures, metrics, and any management commentary or guidance. Reviewing these documents can help retail investors assess recent performance and inform further research or investment decisions.